Home
Features
-
The CDMO/CMO Report: Cell and Gene Therapies
Although a niche market, cell and gene therapy development and manufacturing continues to be an active area of investment by CDMOs/CMOs. Facing limited industry capacity, both pure-play CDMOs and bio/pharma companies with CDMO services continue to expand. A roundup of the latest expansions.
-
Pharma Innovation: AI in Drug Manufacturing
What is the potential of artificial intelligence (AI) in pharmaceutical manufacturing and what regulatory considerations come into play, including between CDMOs/CMOs and sponsor companies? The FDA has issued a discussion paper to highlight key issues and is seeking input from the industry.
-
SPONSORED CONTENT
ICE Pharma Has Launched its Sustainability Report
-
SPONSORED CONTENT
Demonstration of Equivalency Between Two Analytical Methods for the Determination of Loss on Drying (LOD) in Empty Hard Gelatin and Hypromellose Capsules
-
SPONSORED CONTENT
INDENA’S CDMO SERVICES: THE FORMULA FOR CLIENTS’ SUCCESS
DCAT MEMBER COMPANY COMMUNITY
-
Pharma Industry Outlook and Executive Insights at DCAT Week: Online Registration Closes March 15
Online registration for DCAT Week’s education programs closes Wednesday, March 15. Be sure to register in order to get executive insights and the latest market intelligence about the bio/pharma industry’s…
-
New Member Company Alert
Welcome to our Newest Member Companies! We are pleased to welcome the following companies to our DCAT Member Community. From the March 10, 2023 issue of DCAT Value Chain Insights:…
-
View the DCAT Week Preview – 2023 Edition
The NEW DCAT Week Preview, 2023 Edition is available now! This new digital resource replaces our traditional DCAT Week Pocket Guide and provides you an chance to view information from our Member Company community who…
-
Sustainability: Get a C-Suite View of How It Plays in Customer-Supplier Expectations at DCAT Week
Sustainability has become an all-important issue in bio/pharma companies’ selection and evaluation of their suppliers as companies seek to reduce their carbon footprint in line with international climate goals. But…